PROGYNY INC (PGNY)

Progyny, Inc. to Present at BofA Securities 2024 Healthcare Conference and Leerink Partners Healthcare Crossroads Conference 2024

NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

Oversold Conditions For Progyny (PGNY)

RBC Capital Just Raised Its Price Target on Sweetgreen (SG) Stock

Sweetgreen stock is up on Friday after SG shares got positive coverage from RBC Capital analysts alongside Q1 results and steak news.

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.

The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Why Is Progyny (PGNY) Stock Down 27% Today?

Progyny stock is down on Friday after the company posted a revenue miss for Q1 and disappointed PGNY investors with its guidance!

Which stocks are moving before the opening bell on Friday?

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning!

NASDAQ:PGNY—A High-Growth Stock Gearing Up for Its Next Upward Move.

Why PROGYNY INC (NASDAQ:PGNY) Is a Standout High-Growth Stock in a Consolidation Phase.

PGNY Stock Earnings: Progyny Beats EPS, Misses Revenue for Q1 2024

PGNY stock results show that Progyny beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

PGNY Stock Earnings: Progyny Beats EPS, Misses Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Progyny (NASDAQ:PGNY) just reported results for the first quarter of 2024.Progy...

Which stocks are moving after the closing bell on Thursday?

After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Progyny, Inc. Announces First Quarter 2024 Results

Early Sales Activity and New Partnerships Provide Strong Start to Selling Season, Affirming Continued Demand for Fertility and Family Building Solutions

Progyny, Inc. Announces First Quarter 2024 Results

Early Sales Activity and New Partnerships Provide Strong Start to Selling Season, Affirming Continued Demand for Fertility and Family Building Solutions...

Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report

Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of individuals facing family building challenges

Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of...

Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum

NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

The 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024

Wager on these top undervalued mid-cap stocks, effectively blending growth and value, with a remarkable broader-market performance in 2023.

The 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Wagering on mid-cap stocks can potentially unlock investment treasures typicall...

Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

Progyny announces $100M share repurchase program (NASDAQ:PGNY)

Progyny (PGNY) approves $100 million share repurchase program funded by available cash balances.

Progyny, Inc. Announces Share Repurchase Program

Progyny, Inc. Announces Share Repurchase Program

NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

Wednesday Sector Laggards: Hospital & Medical Practitioners, Oil & Gas Refining & Marketing Stocks

Progyny, Inc. Announces Fourth Quarter 2023 Results

Progyny, Inc. Announces Fourth Quarter 2023 Results

Reports Record Full Year Revenue of $1,088.6 Million, Reflecting 38% GrowthAchieves 49% Growth in Adjusted EBITDA to Record $187.1 MillionIssues Financial Guidance for 2024, Crossing the $1.3 Billion Milestone at Midpoint

January 2025 Options Now Available For Progyny (PGNY)

Alabama’s Fertility Ruling Raises Challenges for Stocks of Fertility Benefits Providers

The recent Alabama State Supreme Court ruling on frozen embryos could have national repercussions. Here's what you need to know about it.

Progyny stock slips after Alabama fertility ruling (NASDAQ:PGNY)

Progyny (PGNY) and Accolade (ACCD) drop after the Alabama Supreme Court ruled that frozen embryos can be considered children. Read more here.